Abcann Global (ABCN.V) brings in former Pfizer exec as new CEO
Transitioning from a capital markets CEO to a pharma CEO is a smart move for a licensed cannabis producer about to rapidly expand its output, and that's...
Category: Pharmaceuticals
X-Spray (CND.C) profits from a culture of impatience
At Equity Guru, we sometimes get news before it hits the street. Such is the case with a company called X-Sprays – which is so new it isn’t born yet. Which...
Vinergy (VIN.C) thinks big
In 1856 a 34-year old French microbiologist named Louis Pasteur discovered that heating wine stopped it going bad. Through scientific experimentation Pasteur...
BlueOcean NutraSciences (BOC.V): Flamed out or ready to ignite?
I remember the first time BlueOcean NutraSciences (BOC.V) came to my boardroom. They were amped over something that, they were certain, was going to turn the...
Canabo Medical (CMM.V) delivers game-changing observational weed study
The weed business has one major bottleneck that screws up all business that comes before it. Wanna know what it is? It's this: The positive effects of...
Shell game nears end at Stemcell United (SCU.ASX)
A round of applause to the compliance officers at the ASX, who have finally pulled their finger out and called bullshit on the last 6 months worth of company...
Canabo Medical (CMM.V): More new clinics and financials released
Another day, another new cannabinoid clinic for the boffins at Canabo Medical (CMM.V): this one adding to their tally in Ontario with a new facility in the...
Roundup of ASX listed weed stocks
On the back of our recent piece about the implosion of Stemcell United (which has cratered a further 33% since we released the article) we thought it...
Vinergy Resources/MJ Biopharma (VIN.C) ramps up to clinical testing of CBD therapeutics
Vinergy Resources (VIN.C) may still sound like a mining company, but the innovative CBD product development house acquiring MJ Biopharma is neck deep in its...
VANC Pharmaceuticals (VANC.V) more than doubles as fight for board control ensues
There were a lot of bummed out investors when VANC Pharmaceuticals rolled back their share base recently, but the dip has brought about a very interesting last...
Eff-Marry-Kill: Trawling the ends of the spectrum for sin and savior stock picks
So how do you want to handle the next few years of political madness and megalomania? War might be around the corner, revolution not far behind, and they may...
Canadian marijuana regulation study released: Dispensaries & edibles in, alcohol boards out
Prepare for the next great Canadian marijuana wave. Going against popular wisdom (and, admittedly, what I've been saying for a year now could never happen),...
Emblem Cannabis (EMC.V) lands on the exchange for $215m valuation
I guessed Emblem would drop at around $200m and wasn't far off, but what's been most impressive about the next big marijuana deal's drop into the Venture...
Emblem (EMC.V) debuts Monday morning, will be a monster
Emblem Cannabis (EMC.V) hasn't had to be loud about it. The Canadian investor base has been calling and pleading and goading and pushing to get in on its...
CannaRoyalty (CRZ.C) debuts on CSE, blows up to $150m market cap
Typical. Not one to let an opportunity pass by without grabbing another damn asset, Marc Lustig at CannaRoyalty (formerly Cannabis Royalties) today announced...
